The tenascin family of ECM glycoproteins: Structure, function, and regulation during embryonic development and tissue remodeling

By F. S. Jones, P. Jones. Developmental Dynamics, 2000

704 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Tight junctions of the blood-brain barrier: development, composition and regulation. (2002, background): “The mechanisms include the secretion of growth factors, expression and activation of MMPs (serine proteases) and an increase in specific matrix components like tenascin-C (Conant et al., 1999;Westermark and Kahari, 1999; Jones et al., 1997; Fischer et al., 1999; Plate et al., 1992; Hermansson et al.”
Matrix MetalloProteinases (MMPs) andTissue Inhibitors of MetalloProteinases (TIMPs): positive and negative regulators intumor cell adhesion (2010, neutral): “Detailed description of matrix protein family members, their functions and role in human pathologies are provided in recent reviews [17–21].”
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. (2003, background): “In contrast to the absence or low level of expression of ECM components found in the adult gland, we detected abundant expression of embryonic ECM components, including tenascin and decorin, in mammospheres (Fig. 2Q,R; Jones and Jones 2000; Kresse and Schonherr 2001).”
Functional structure and composition of the extracellular matrix (2003, background): “This indeed appears to be the case [14].”